Results 191 to 200 of about 3,880 (235)
Connectivity profiles of the insular network for speech control in healthy individuals and patients with spasmodic dysphonia. [PDF]
Battistella G, Kumar V, Simonyan K.
europepmc +1 more source
Impaired Limb Proprioception in Adults With Spasmodic Dysphonia. [PDF]
Konczak J+4 more
europepmc +1 more source
Factors Affecting Compliance with Botulinum Toxin Injection in Spasmodic Dysphonia Patients
Nupur Kapoor Nerurkar+2 more
openalex +1 more source
Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.
Patel PN+8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2020
Spasmodic dysphonia (SD) is a rare focal laryngeal dystonia. It is characterized by task-specific voice dysfluency resulting from selective intrinsic laryngeal musculature hyperfunction. Symptoms may be attenuated by a sensory trick. Although SD can be seen at times in generalized dystonia syndromes, it is typically a sporadic phenomenon.
Jiahui, Lin, Babak, Sadoughi
openaire +2 more sources
Spasmodic dysphonia (SD) is a rare focal laryngeal dystonia. It is characterized by task-specific voice dysfluency resulting from selective intrinsic laryngeal musculature hyperfunction. Symptoms may be attenuated by a sensory trick. Although SD can be seen at times in generalized dystonia syndromes, it is typically a sporadic phenomenon.
Jiahui, Lin, Babak, Sadoughi
openaire +2 more sources
Laboratory Evaluation of Spasmodic Dysphonia
Journal of Voice, 2020To evaluate the utility of comprehensive laboratory evaluation in patients with spasmodic dysphonia (SD).Retrospective chart review.A review of the medical records of 40 patients diagnosed with spasmodic dysphonia from 2009-2018 was preformed to evaluate abnormal test results that were significant when compared with abnormal results of the general ...
Rohan Patel+4 more
openaire +3 more sources
Botulinum toxin for spasmodic dysphonia
Physical Medicine and Rehabilitation Clinics of North America, 2003Botulinum toxin is the accepted method of managing SD and has given most patients with adductor SD the ability to develop satisfactory vocal function. Results have been less satisfactory in abductor SD. Management is accomplished best with a team approach.
Christopher R. Watts+2 more
openaire +5 more sources
Treatment Options in Spasmodic Dysphonia
Otolaryngologic Clinics of North America, 1991Options in the treatment of spasmodic dysphonia include surgical interruption of the recurrent laryngeal nerve, anterior laryngoplasty, voice therapy, and Botulinum toxin injection. Although none of these treatments is ideal, Botulinum toxin injection appears to have the greatest potential to benefit the greatest number of patients.
Robert H. Miller, Gayle E. Woodson
openaire +3 more sources